A SYNDROME OF LYMPHOBLASTIC LYMPHOMA, EOSINOPHILIA, AND MYELOID HYPERPLASIA MALIGNANCY ASSOCIATED WITH T(8-13) (P11-Q11) - DESCRIPTION OF ADISTINCTIVE CLINICOPATHOLOGICAL ENTITY
Rc. Inhorn et al., A SYNDROME OF LYMPHOBLASTIC LYMPHOMA, EOSINOPHILIA, AND MYELOID HYPERPLASIA MALIGNANCY ASSOCIATED WITH T(8-13) (P11-Q11) - DESCRIPTION OF ADISTINCTIVE CLINICOPATHOLOGICAL ENTITY, Blood, 85(7), 1995, pp. 1881-1887
We report two patients with a distinctive biphenotypic hematologic dis
order characterized by lymphoblastic lymphoma (LBL), eosinophilia, and
myeloid malignancy and/or hyperplasia associated with a t(8;13)(p11;q
11) chromosomal translocation in both bone marrow and lymph node speci
mens. Both patients presented with lymphadenopathy pathologically clas
sified as LBL with a T-cell immunophenotype, myeloid hyperplasia of th
e bone marrow, and peripheral blood eosinophilia. The first patient ac
hieved clinical complete remission after receiving several regimens of
chemotherapy and remains disease-free 16 months after undergoing allo
geneic bone marrow transplantation. The second patient developed progr
essive lymphadenopathy despite several courses of chemotherapy directe
d against non-Hodgkin's lymphoma. Eight months after his initial prese
ntation, he developed acute myelogenous leukemia that was refractory t
o therapy. Comparison of these patients with four similar cases recent
ly reported in the literature suggests that this constellation of find
ings constitutes a distinctive clinicopathologic syndrome. Molecular a
nalysis of the t(8;13) translocation breakpoint may identify genes loc
ated in this region and provide insight into the pathogenesis of this
interesting biphenotypic hematologic malignancy. (C) 1995 by The Ameri
can Society of Hematology.